NCT00111904View on ClinicalTrials.gov

Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

August 31, 2007

Conditions
Pancreatic Cancer
Interventions
DRUG

paclitaxel-loaded polymeric micelle

Trial Locations (5)

10011

St. Vincent's Comprehensive Cancer Center - Manhattan, New York

34135

Florida Cancer Specialists - Bonita Springs, Bonita Springs

60077

Midwest Cancer Research Group, Incorporated, Skokie

70506

Louisiana Oncology Associates - Lafayette, Lafayette

78705

Southwest Regional Cancer Center - Central, Austin

Sponsors

Lead Sponsor

Theradex
All Listed Sponsors
lead

Theradex

INDUSTRY

NCT00111904 - Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter